Take part in this unique event by registering now to meet all the stakeholders of the emerging markets for the life sciences industry!
October 8th, 2014 – Cité Universitaire of Paris
MARKET ACCESS INSIGHTS
– Emerging Markets at a glance
– Where to find successful industries?
– Emerging markets as a source of innovation?
– Make the best of local specificities and talents
– Where to play? Focus on countries by therapeutic area and segment
Speakers:
Rafi Mardachti, CEO, Universal Medica Group
Ken Genenz, Director, Simon-Kucher & Partners
Ken Genenz, Director, Simon-Kucher & Partners
FOCUS ON MENA REGION
– Regional and local specificities
– Case study from a successful player
– Round table discussion involving industry and local institutions
Speakers:
Madal Lavanya, Account Manager – Healthcare at Memac, Ogilvy
Mohamed Khalil Allouche, Market Research & Business Development Manager, Pfizer
Gaël Le Rouzo, Commercial Director – Far East, SANZAR & North Africa, Eusa Pharma
Yildiz Levent, Head of Market Access Middle East, Africa & Turkey, Boehringer
BRAZILIAN PHARMA MARKET
Global companies are currently missing a significant opportunity to make profits which would serve a big part of the country to grow strong and fast.
Speakers:
Tracy Francis, Principal, McKinsey´s Healthcare
Stephen J. Clark, Vice President of Business Development and Consulting, Life Sciences, Optum
Eduardo Calderari, Market Access & Institutional Affairs Director, Bayer
Catherine David, Market Access Expert, Biotika
RUSSIA PHARMA MARKET
With competition and regulation increasing drastically in a fast growing market, companies face new challenges and must be better prepared.
Speakers:
Pavel Gerasimov, MA Manager of Oncology BF, Novartis
Nikita Minaev, Head of Grindeks office, Grindeks
Galina Sekareva, Head of Legal Department, Biocad
CHINESE PHARMA MARKET
China’s pharmaceutical industry is entering a critical period of transformation as it is losing its traditional competitiveness, such as fares, and is also facing a sluggish international market, especially in Europe and the United States.
Speakers:
Gaël Le Rouzo, Commercial Director – Far East, SANZAR & North Africa , Eusa Pharma
Siham Brulais, Director Global Pricing and Market Access, Ipsen
INDIAN PHARMA MARKET
Expertise in generics and vaccines & a considerable manufacturing capacity, India’s industry could prove either a powerful partner or a competitor. What are the stakes in this sophisticated pharma industry?
Speakers:
Dr. Rashmi Kulshrestha, Regulatory Consultant, Regulatory Wisdom
Susan Josi, Managing Partner, Sorento healthcare communications PVT LTD
Dr. Deepak Sapra, Director, Reddy’s laboratories LTD
Bhadresh H Khamar, Director, Kegan executive search